Correction: MiR-124 acts as a target for Alzheimer's disease by regulating BACE1

Fengmao An^{1

2}, Guohua Gong^{1

2

3}, Yu Wang^{1

2}, Ming Bian^{1

2}, Lijun Yu^{1

2}, Chengxi Wei^{1

2}

Affiliations

¹ Medicinal Chemistry and Pharmacology Institute, Inner Mongolia University for The Nationalities, Tongliao, Inner Mongolia, P.R. China.
² Inner Mongolia Key Laboratory of Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System, Tongliao, Inner Mongolia, P.R. China.
³ First Clinical Medical of Inner Mongolia University for Nationalities, Tongliao, Inner Mongolia, P.R. China.

Published Erratum

Fengmao An et al. Oncotarget. 2018.

. 2018 May 15;9(37):24871.

doi: 10.18632/oncotarget.25461.

Fengmao An^{1

2}, Guohua Gong^{1

2

3}, Yu Wang^{1

2}, Ming Bian^{1

2}, Lijun Yu^{1

2}, Chengxi Wei^{1

2}

¹ Medicinal Chemistry and Pharmacology Institute, Inner Mongolia University for The Nationalities, Tongliao, Inner Mongolia, P.R. China.
² Inner Mongolia Key Laboratory of Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System, Tongliao, Inner Mongolia, P.R. China.
³ First Clinical Medical of Inner Mongolia University for Nationalities, Tongliao, Inner Mongolia, P.R. China.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.23119.].

MiR-124 acts as a target for Alzheimer's disease by regulating BACE1.
An F, Gong G, Wang Y, Bian M, Yu L, Wei C. An F, et al. Oncotarget. 2017 Dec 9;8(69):114065-114071. doi: 10.18632/oncotarget.23119. eCollection 2017 Dec 26. Oncotarget. 2017. PMID: 29371969 Free PMC article.